These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21093078)

  • 1. Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models.
    Lin GM; Chu KM; Han CL
    Int J Cardiol; 2011 Feb; 146(3):422-3. PubMed ID: 21093078
    [No Abstract]   [Full Text] [Related]  

  • 2. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
    Blankenberg S; Yusuf S
    Circulation; 2006 Oct; 114(15):1557-60. PubMed ID: 17030701
    [No Abstract]   [Full Text] [Related]  

  • 3. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.
    Scirica BM; Morrow DA
    Circulation; 2006 May; 113(17):2128-34; discussion 2151. PubMed ID: 16651484
    [No Abstract]   [Full Text] [Related]  

  • 4. C-reactive protein is a bystander of cardiovascular disease.
    Anand SS; Yusuf S
    Eur Heart J; 2010 Sep; 31(17):2092-6. PubMed ID: 20675658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory process during childhood and the risk of developing atheromatous disease in adult life: the role of C-reactive protein.
    Lefkou E; Fragakis N; Varlamis G
    Hellenic J Cardiol; 2006; 47(3):164-9. PubMed ID: 16862825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis, inflammation, and C-reactive protein.
    Harv Mens Health Watch; 2006 Aug; 11(1):6. PubMed ID: 17111477
    [No Abstract]   [Full Text] [Related]  

  • 8. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis.
    Mangge H; Schauenstein K; Stroedter L; Griesl A; Maerz W; Borkenstein M
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):378-82. PubMed ID: 15239023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients.
    Kahraman S; Yilmaz R; Akinci D; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    J Ren Nutr; 2005 Oct; 15(4):377-86. PubMed ID: 16198930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
    Montero I; Orbe J; Varo N; Beloqui O; Monreal JI; Rodríguez JA; Díez J; Libby P; Páramo JA
    J Am Coll Cardiol; 2006 Apr; 47(7):1369-78. PubMed ID: 16580524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherosclerosis--the chronic inflammation of vessel wall].
    Feng ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):393-4. PubMed ID: 15932690
    [No Abstract]   [Full Text] [Related]  

  • 12. CRP as a mediator of disease.
    Yeh ET
    Circulation; 2004 Jun; 109(21 Suppl 1):II11-4. PubMed ID: 15173057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in hypertension: primary evidence.
    Li JJ
    Chin Med J (Engl); 2006 Jul; 119(14):1215-21. PubMed ID: 16863616
    [No Abstract]   [Full Text] [Related]  

  • 14. C-reactive protein in atherosclerosis: A causal factor?
    Paffen E; DeMaat MP
    Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and statins: by Jupiter!
    Wardle EN
    Nephrol Dial Transplant; 2009 Nov; 24(11):3552; author reply 3552. PubMed ID: 19692416
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in atrial fibrillation and atherosclerosis: pearls and pitfalls in the theorising process.
    Gupta VK
    Int J Clin Pract; 2006 Apr; 60(4):495-6; author reply 497-8. PubMed ID: 16620366
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of obesity with inflammation in chronic kidney disease: a cross-sectional study.
    Ramkumar N; Cheung AK; Pappas LM; Roberts WL; Beddhu S
    J Ren Nutr; 2004 Oct; 14(4):201-7. PubMed ID: 15483779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of weight loss and dietary fatty acids on inflammation.
    Devaraj S; Kasim-Karakas S; Jialal I
    Curr Atheroscler Rep; 2006 Nov; 8(6):477-86. PubMed ID: 17045074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.